Uzbekistan is celebrating the registration of two WHO-prequalified (PQ) tuberculosis medicines, cycloserine and prothionamide, using the Collaborative Procedure Accelerated Registration (CPAR) process. CPAR fast-tracks registration for medicines that have WHO PQ or are already registered by a stringent regulatory authority. The process improves information sharing between the WHO Prequalification of Medicines Program and national medicines regulatory authorities. It also helps avoid delays in registration, helps medical products reach patients more quickly, and ensures the uninterrupted supply of medicines. In addition, the reduced registration fee should encourage the registration of other WHO PQ medicines in country. PQM+ is also working with Bangladesh to put in place the mechanisms needed to use CPAR there.